Abstract:Objective To explore the histopathological changes of bile duct,liver and local tissue for injurious biliary stricture(IBS). Method To observe the morphological and pathological changes of bile duct, local tissue and liver in different periods with dogs as the established animal model for IBS. Result Bile duct obstruction due to injury can expand the proximal bile duct up to 18.91 ±1.85 mm as the pressure goes up. Damage to local tissue triggers acute inflammation. In early injury phase (within 10 d), inflammatory cell infiltration and proliferation appears on the wall of the duct with increased mucosal edema as well as thickening of the biliary ductile wall. In the late injury phase (15 d), the degree of infiltration of inflammatory cells, edema and mucosal thickness were reduced whereas fibroblast and collagen tissue were proliferated extensively. The wall of biliary duct also becomes fibrotic and thickens. Quantitative analysis of the inflammatory edema shows the most severe outcome on the 5th day (HE staining WBC count of 54.2±5.8 unit) and its severity progressively subsides on the 15th day. (HE staining WBC count of 41.7±7.2 vs 54.2±5.8 a, P＜0.0,5). In the early obstruction (5 d and 10 d), the liver cells showed mild to moderate swelling and its degeneration is often associated with steatosis and sinusoidal expansion and congestion. As the obstruction time increases in the 20 d and 30 d group, liver cells starts to show extensive vacuolation and sinusoidal occlusion. Conclusions Early phase (5 days) of acute bile duct obstruction due to injury shows rapid expansion of the bile duct, edema in the bile duct itself as well as its surrounding tissue and liver damage. After 15 days, the local inflammatory edema is greatly reduced and is replaced by hyperplasia of fibers and collagen. Liver damage appears to be irreversible after 20 days. Considering local environmental and systemic conditions, the optimal time frame to repair obstruction of bile duct surgically is between 10-20 days.

Nuclear factor KB and its inhibiting factor in the expression and significance in the process of benign biliary stricture formation

Expressions and significance of TGF-β_1 and TβRⅠ in benign biliary stricture

Expression and Significance of TGF-β1 and COX-2 in Benign Biliary Stricture

Role of Transforming Growth Factor-Beta Signaling Pathway in Pathogenesis of Benign Biliary Stricture.

An Experimental Study on Mechanism of Benign Biliary Stricture

Mechanism of benign biliary stricture: a morphological and immunohistochemical study.

Expression of transforming growth factor -β signalling pathway in the benign biliary stricture

The expression and significance of caspase3 and cIAP-1 in the wound healing process of bile duct

Expression and significance of Smad4/Smad7 in benign biliary stricture

Expression of CTGF in benign biliary stricture and its significance

IL-17A produced by invariant natural killer T cells and CD3(+)CD56(+)alpha Galcer-CD1d tetramer(-) T cells promote liver fibrosis in patients with primary biliary cholangitis

Experimental Observation of Pathological Changes in the Tissues after Injurious Biliary Stricture

NF-κB Related Abnormal Hyper-Expression of Inos and NO Correlates with the Inflammation Procedure in Biliary Atresia Livers

THE EXPRESSION AND SIGNIFICANCE OF TRANSFORMING GROWTH FACTOR-β1 IN THE HEALING PROCESS OF BILE DUCT

A Study on the Expressions and the Correlation of TGF-β 1 , and A-Sma in Healing Process of Bile Duct Trauma

Expressions of Prostaglandin F2α Receptor and Cyclooxygenase-2 in Tissue of Benign Bile Duct Scar and Their Significances

Temporal expression of scar formation-related factors in obstructive bile duct injury

Microstructural and Ultrastructural Changes in the Healing Process of Bile Duct Trauma.

Effect of nuclear factor kappa B on TNF-α induced proliferation,apoptosis and the expression of TGF-β_1 in airway smooth muscle cells

Expression of Nuclear Factor-κB and Its Clinical Significance in Nonsmall-Cell Lung Cancer

Implication of macrophages and transforming growth factor-β1 expression in the healing process of bile duct